Stockreport

U.S. FDA approves injectable version of cancer drug from Bristol Myers Squibb [Globe and Mail, The (Toronto, Canada)]

Merck & Company, Inc. (new)  (MRK) 
Last merck & company, inc. (new) earnings: 4/28 06:45 am Check Earnings Report
US:NYSE Investor Relations: investors.merck.com/home/default.aspx
PDF decrease blockbuster cancer drug, Opdivo. Opdivo is part of a class of drugs called PD-1 inhibitors, which enhance the immune system's ability to fight cancer by remo [Read more]